-
Model-informed development of a cost-saving dosing regimen for enfortumab vedotin
op ’t Hoog, C. J. P., Rieborn, A., Moes, D. J. A. R., Hendrikx, J. J. M., van der Heijden, M. S., Franken, M. D., van der Hulle, T., van Kruchten, M., Willemsen, A. E. C. B., Koolen, S. L. W., Boerrigter, E. & ter Heine, R., 1 Dec 2025, In: Cancer chemotherapy and pharmacology. 95, 1, 36.Research output: Contribution to journal › Article* › Academic › peer-review
-
Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications
Vis, D. J., Palit, S. A. L., Corradi, M., Cuppen, E., Mehra, N., Lolkema, M. P., Wessels, L. F. A., van der Heijden, M. S., Zwart, W. & Bergman, A. M., 1 Dec 2025, In: Genome medicine. 17, 1, 24.Research output: Contribution to journal › Article* › Academic › peer-review
-
Properties of CD8 T-cell-recognized neoantigens in different tumor types
Ketelaars, S. L. C., van Buuren, M. M., Gangaev, A., van Rooij, N., Patiwael, S., Hoefakker, K., Fanchi, L. F., Baas, P., van der Heijden, M., Kok, M., Schumacher, T. N., Kvistborg, P. & Haanen, J. B. A. G., 1 Sept 2025, In: Immuno-Oncology and Technology. 27, 101062.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
